Global Hemophilia Market Report: 2013
Edition
Hemophilia
is a disorder in which the blood does not clot properly, leading to extended
bleeding. The bleeding can be external or internal, especially in the knees,
ankles, and elbows. There are two types of hemophilia: type A and type B. The
market has been growing since past several years mainly due to improvement in
technology, discovery of new coagulation factors, proteins, and plasma
concentrates which are being used for treating chronic diseases and medical
conditions.
To
Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/global-hemophilia-market-report-2013-edition
As
more people suffer with Hemophilia A in comparison with Hemophilia B and
Inhibitors, the Hemophilia A market is the largest in the world. The US
accounts for the major population suffering with hemophilia globally.
The
key trends observed within the market include inclination towards prophylaxis,
long-acting factor VIII and IX development and growing penetration of rFVIII
products in emerging markets which is a opportunity for manufacturers. On the
development front, there has been an increase in the launch of new products by
various companies. But there are certain challenges which the industry is
facing as of now which include risk of antibody neutralization, emerging
challenges for developing nations and rising cost of hemophilia treatment. The
major factors which will contribute in the growth of the industry include
rising male population, increasing expenditure on healthcare and increasing new
patient registration.
The
report studies the hemophilia market on a global scale and its various
segments. The competition in the global hemophilia market is intense with few
large players viz. Baxter, Grifols, Pfizer and Nova Noridisk. The competitive
landscape along with the company profiles of the leading players in the market
is discussed in detail.
By
combining SPSS Inc.’s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the industry. We
employed various significant variables that have an impact on this industry and
created regression models with SPSS Base to determine the future direction of
the industry. Before deploying the regression model, the relationship between
several independent or predictor variables and the dependent variable was
analyzed using standard SPSS output, including charts, tables and tests.
TABLE
OF CONTENT
1.
Hemophilia: An Overview
Sign
& Symptoms
Types
of Hemophilia
Treatment
2.
Market Overview
2.1
Global Hemophilia Market
Market
Value
Patient
Volume
2.2
Hemophilia Market by Segments
2.2.1
Hemophilia A
Market
Value
Patient
Volume
Key
Products Comparison
FVIII
Market
2.2.2
Hemophilia B
Market
Value
Patient
Volume
Key
Products Comparison
FIX
Market
2.2.3
Hemophilia with Inhibitor
Market
Value
Patient
Volume
Key
Products
2.2.4
Von Willebrand Disease
2.3
Hemophilia Market by Region
2.3.1
Australia
2.3.2
The US
Market
Value
Patient
Volume
Market
Segments
FVIII
Market
FIX
Market
For
More Information Diseases &
Conditions Market Research Reports @:
3.
Market Dynamics
3.1
Key Trends
3.1.1
Shift towards Prophylaxis
3.1.2
Long-Acting Factor VIII and IX Development
3.1.3
Rising Penetration of rFVIII Products in Emerging Markets
3.2
Growth Drivers
3.2.1
Rising Male Population
3.2.2
Increasing Expenditure on Healthcare
3.2.3
Increasing New Patient Registration
3.3
Significant Developments
3.3.1
Baxter Announced ADVATE Approval in China
3.3.2
Baxter Expands Access to Recombinant FVIII Hemophilia Treatment in Brazil
3.3.3
Novo Nordisk Files New Hemophilia Drug in EU, US
3.4
Challenges
3.4.1
Risk of Antibody Neutralization
3.4.2
Emerging Challenges for Developing Nations
3.4.3
Rising Cost of Hemophilia Treatment
4.
Competitive Scenario
Market
Share
Product
Comparison
5.
Company Profiles
5.1
Baxter International Inc.
5.1.1
Business Overview
5.1.2
Financial Overview
5.1.3
Business Strategies
Advancement
of Core Portfolio
Expansion
of Product Portfolio
5.2
Grifols
5.2.1
Business Overview
5.2.2
Financial Overview
5.2.3
Business Strategies
Expansion
in Other Geographic Regions
Growth
through Mergers & Acquisitions
5.3
Novo Nordisk
5.3.1
Business Description
5.3.2
Financial Highlights
5.3.3
Business Strategies
Product
Innovation
5.4
Pfizer, Inc.
5.4.1
Business Overview
5.4.2
Financial Highlights
5.4.3
Business Strategies
Expansion
in Emerging Markets
Growth
through Acquisitions
About
Us
Marketresearchreports.biz
is the most comprehensive collection of market research reports.
Marketresearchreports.biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
With a team of
experienced consultants we are committed to serve our clients in a way which
increase their efficiency, reduce costs and saves time. Our professional search
engine helps you in finding the best and latest market research report with
just one click of the mouse. Our database represents the most updates and
latest market research report collections form all the leading market research
publishers across the globe
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment